The Lymphoma Channel on VJHemOnc is an independent medical education platform, supported with funding from AstraZeneca (Diamond), BMS (Gold), Johnson & Johnson (Gold), Takeda (Silver) and Galapagos (Bronze). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
Welcome to The Burkitt Lymphoma Channel
VJHemOnc brings you the newest advances in the field of Burkitt lymphoma, with video interviews, podcasts, and roundtable discussions from the experts. The Burkitt Lymphoma Channel provides coverage from key congresses with insightful commentary on the latest developments in diagnosing Burkitt lymphoma, novel combination and CAR-T therapies, and more.
